Guidelines for the management of adult lower respiratory tract infections
By M. Woodhead, F. Blasi, S. Ewig, G. Huchon, M. Leven, A. Ortqvist, T. Schaberg, A. Torres, G. M. van der Heijden, T. Verheij. European Respiratory Journal, 2005
948 citations recorded by the source corpus.
Subfields: Emergency Medical Services, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/202c91cb2cd73f6a05a1c4061aa46f60650a3047
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Emergency Medical Services
In Pulmonary and Respiratory Medicine
- D. Parums
- P. Barnes
- R. Rodríguez-Roisín
- C. Jenkins
- Sonia Buist
- Jan Zieliński
- Yoshinosuke Fukuchi
- Jorgen Vestbo
Citations in the corpus
- Guidelines for the management of adult lower respiratory tract infections - Full version (2011, neutral): “Using the same search filter as for the 2005 document (this is described in detail in the previous publication [1] and website documents—http://www.”
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. (2017, background): “Exacerbations are mainly triggered by respiratory viral infections although bacterial infections and environmental factors may also initiate and/or amplify these events.(240)”
- Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (2007, background): “In summary, antibiotics should be given to patients with exacerbations of COPD who have three cardinal symptoms—increase in dyspnea, sputum volume, and sputum purulence (Evidence B); patients who have two of the cardinal symptoms, if increased purulence of sputum is one of the two symptoms (Evidence”
- Clinical and economic burden of community-acquired pneumonia among adults in Europe (2010, methodology): “These guidelines also stress the possibility of a viral cause for pneumonia and offer recommendations for prevention of LRTI by vaccination and other methods.(7) Empirical antibiotic coverage of atypical pathogens does not reducemortalityor improve clinical efficacy inhospitalisedpatients with CAP.”
- Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution (2023, positive): “Таким образом, антибиотики следует назначать паци" ентам с обострением ХОБЛ, у которых имеются три глав" ных симптома – усиление одышки, увеличение объема мокроты и усиление гнойного характера мокроты (уро> вень доказательности B); либо имеются два главных симптома обострения, причем один из этих дв”
- Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. (2009, neutral): “Respiratory rate, median (IQR), breaths/min 20 (16-25) 20 (16-26) 20 (16-25)”
- Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications (2010, background): “In humans, the cytokine profile for 23 subjects with CAP treated with clarithromycin at 500 mg twice daily for 7 days was compared with that for subjects treated with amoxicillin at 1 g three times daily for 7 days.”